Related Experiment Video
Updated: Aug 8, 2026

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF
Leila Gobejishvili1, Shirish Barve, Swati Joshi-Barve
1Dept. of Medicine, Pharmacology and Toxicology, Univ. of Louisville Medical Center, 550 S. Jackson St., ACB 3rd Floor, Louisville, KY 40292, USA. craig.mcclain@louisville.edu
Chronic ethanol exposure decreases cellular cAMP levels, increasing TNF-alpha production in monocytes. This suggests cAMP-elevating agents may treat alcoholic liver disease (ALD).
Area of Science:
- Hepatology
- Immunology
- Molecular Biology
Background:
- Alcoholic liver disease (ALD) pathogenesis involves increased TNF-alpha.
- Monocytes from alcoholic patients exhibit enhanced NF-kappaB activation and TNF-alpha production.
- Cellular cAMP regulates TNF-alpha expression, with elevated cAMP suppressing production.
Purpose of the Study:
- To investigate the effects of chronic ethanol exposure on cAMP levels and TNF expression in monocytes and Kupffer cells.
- To elucidate the role of cAMP in ethanol-induced TNF-alpha production in ALD.
Main Methods:
- In vitro and in vivo (rat model) experiments.
- Analysis of cellular cAMP levels in monocytes and Kupffer cells.
- Assessment of TNF-alpha production and NF-kappaB activation.
- Evaluation of TNF mRNA expression and stability.
- Intervention with dibutyryl cAMP to modulate cAMP levels.
Main Results:
- Chronic ethanol exposure significantly decreased cellular cAMP levels in monocytes.
- Ethanol increased LPS-inducible TNF-alpha production by affecting NF-kappaB activation and TNF mRNA induction.
- cAMP enhancement abrogated LPS-mediated TNF-alpha expression in ethanol-treated cells.
- cAMP decreased NF-kappaB transcriptional activity but not its activation.
Conclusions:
- Ethanol synergizes with LPS to upregulate TNF gene expression and TNF overproduction by reducing cellular cAMP levels in monocytes/macrophages.
- cAMP-elevating agents show therapeutic potential for attenuating ALD progression.
Related Concept Videos
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Inflammation: Introduction
Cirrhosis II: Pathophysiology

